MicroBase(3184) Unveiling a New Era in Nebulization Therapy by TechNice

Thanks for the interview with TechNice. It provided MicroBase with the opportunity to share innovative ideas and to introduce the LoyalCare inline nebulizer to a broader audience.


Hengguang Chen, TechNice


According to the Ministry of Health and Welfare's statistics for the year 2022, pneumonia ranks ninth among individuals aged 45-64, but escalates to the third position for those aged 65 and above. Moreover, air pollution is identified as a significant factor contributing to a higher incidence of lower respiratory diseases, MicroBase Technology views the medical industry as the focal point of its corporate strategy, emphasizing excellent quality and wholehearted medical care as core values. The company prioritizes investments in research and development, aiming to develop smarter and more effective medical devices that enhance efficiency and improve the patient experience.
 

►【Link】


Back